This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Aragon Pharmaceuticals, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Dennis Martin Hester: Innovator in Anticancer Compositions
Introduction
Dennis Martin Hester is a notable inventor based in San Diego, CA. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anticancer compositions. His work focuses on innovative formulations that target androgen receptor-related diseases, especially prostate cancer.
Latest Patents
Dennis holds a patent for anticancer compositions, specifically concerning pharmaceutical formulations of ARN-509. This invention is designed for administration to mammals, particularly humans, suffering from various forms of prostate cancer. The formulations include a solid dispersion of ARN-509 and HPMCAS, which can be produced through methods such as melt-extrusion or spray drying.
Career Highlights
Dennis is associated with Aragon Pharmaceuticals, Inc., where he has been instrumental in advancing cancer treatment options. His research and development efforts have led to the creation of effective pharmaceutical formulations that address critical health issues.
Collaborations
Dennis collaborates with Jason Michael Vaughn, contributing to the innovative work being done at Aragon Pharmaceuticals, Inc. Their partnership exemplifies the importance of teamwork in the field of pharmaceutical research.
Conclusion
Dennis Martin Hester's contributions to anticancer compositions highlight his commitment to improving treatment options for prostate cancer. His innovative work continues to impact the pharmaceutical industry positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile